-
ICD-10-CM Codes
›
-
D50-D89
Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism
›
-
D65-D69
Coagulation defects, purpura and other hemorrhagic conditions
›
-
D68-
Other coagulation defects
›
2018 ICD-10-CM Diagnosis Code D68.31
Hemorrhagic disorder due to intrinsic circulating anticoagulants, antibodies, or inhibitors
2016 2017 2018 Non-Billable/Non-Specific Code
- D68.31 should not be used for reimbursement purposes as there are multiple codes below it that contain a greater level of detail.
- Short description: Hemorrhagic disorder due to intrns circ anticoag,antib,inhib
- The 2018 edition of ICD-10-CM D68.31 became effective on October 1, 2017.
- This is the American ICD-10-CM version of D68.31 - other international versions of ICD-10 D68.31 may differ.
The following code(s) above
D68.31 contain annotation back-references
Annotation Back-References
In this context, annotation back-references refer to codes that contain:
- Applicable To annotations, or
- Code Also annotations, or
- Code First annotations, or
- Excludes1 annotations, or
- Excludes2 annotations, or
- Includes annotations, or
- Note annotations, or
- Use Additional annotations
that may be applicable to
D68.31:
- Hemorrhagic disord due to circulatin anticoagulant
- Hemorrhagic disorder due to circulating anticoagulants
Code History
- 2016 (effective 10/1/2015): New code (first year of non-draft ICD-10-CM)
- 2017 (effective 10/1/2016): No change
- 2018 (effective 10/1/2017): No change
ICD-10-CM Codes Adjacent To D68.31
D64.89 Other specified anemias
D64.9 Anemia, unspecified
D65 Disseminated intravascular coagulation [defibrination syndrome]
D66 Hereditary factor VIII deficiency
D67 Hereditary factor IX deficiency
D68 Other coagulation defects
D68.0 Von Willebrand's disease
D68.1 Hereditary factor XI deficiency
D68.2 Hereditary deficiency of other clotting factors
D68.3 Hemorrhagic disorder due to circulating anticoagulants
D68.31
Hemorrhagic disorder due to intrinsic circulating anticoagulants, antibodies, or inhibitors
D68.312 Antiphospholipid antibody with hemorrhagic disorder
D68.318 Other hemorrhagic disorder due to intrinsic circulating anticoagulants, antibodies, or inhibitors
D68.32 Hemorrhagic disorder due to extrinsic circulating anticoagulants
D68.4 Acquired coagulation factor deficiency
D68.5 Primary thrombophilia
D68.51 Activated protein C resistance
D68.52 Prothrombin gene mutation
D68.59 Other primary thrombophilia
D68.6 Other thrombophilia
Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.
